Drugplain

DICLEGIS 10 mg/1

doxylamine succinate and pyridoxine hydrochloride · TABLET, DELAYED RELEASE · Duchesnay USA, Inc.

No Recall History
Plain English

DICLEGIS is a tablet, delayed release containing doxylamine succinate and pyridoxine hydrochloride at 10 mg/1, taken oral. Manufactured by Duchesnay USA, Inc..

Key Facts

Brand Name
DICLEGIS
Generic Name
doxylamine succinate and pyridoxine hydrochloride
NDC Code (Product)
55494-100
Manufacturer
Duchesnay USA, Inc.
Strength
10 mg/1
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Marketing Status
Application #
NDA021876
Marketing Start
05/15/2013

Recall History

No Recall History

Frequently Asked Questions

What is DICLEGIS used for?

DICLEGIS contains doxylamine succinate and pyridoxine hydrochloride. It is a tablet, delayed release taken oral. Consult your doctor for specific uses.

Is DICLEGIS a controlled substance?

DICLEGIS is not classified as a controlled substance by the DEA.

What is the generic name for DICLEGIS?

The generic name for DICLEGIS is doxylamine succinate and pyridoxine hydrochloride. There are 8 other brand versions of doxylamine succinate and pyridoxine hydrochloride.

What is the NDC code for DICLEGIS 10 mg/1?

The NDC (National Drug Code) for DICLEGIS 10 mg/1 is 55494-100, listed by Duchesnay USA, Inc..